Business
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health
Reported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026Diluted EPS of $3.91 and Adjusted Diluted EPS of $4.38 in fiscal year 2026Announces agreement to acquire LaCorium Health, a leader in Australian therapeutic skin careIntroducing Outlook for Fiscal 2027 Organic Revenue Growth and Adjusted Diluted EPS of 1% to 3%, respectively, excluding the impact of acquisitions TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today rep
About this update from Prestige Consumer Healthcare Inc.
[{"type":"image","alt":"Prestige Consumer Healthcare Inc.","displaySize":"","headline":null,"caption":"Prestige Consumer Healthcare Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":102,"url":"https://media.zenfs.com/en/globenewswire.com/1b5655ca12a92f858081df51ed2ce36b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FLwmlDskH0PHRRLgz3xb6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1b5655ca12a92f858081df51ed2ce36b","width":300,"height":102},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/FLwmlDskH0PHRRLgz3xb6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1b5655ca12a92f858081df51ed2ce36b","width":300,"height":102}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted EPS of $3.91 and Adjusted Diluted EPS of $4.38 in fiscal year 2026","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Announces agreement to acquire LaCorium Health, a leader in Australian therapeutic skin care","length":92,"tagName":"p"}]},{"val":[{"type":"text","content":"Introducing Outlook for Fiscal 2027 Organic Revenue Growth and Adjusted Diluted EPS of 1% to 3%, respectively, excluding the impact of acquisitions","length":147,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":395,"olType":false},{"type":"text","content":"TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026.","length":188,"tagName":"p"},{"type":"text","content":"“Our fiscal 2026 demonstrated the resilience of our business model in a challenging consumer backdrop.","length":102,"tagName":"p"},{"type":"text","content":"Our diversified portfolio of leading brands with deep consumer heritage supports a durable financial profile and drives strong, growing free cash flow. In fiscal 2026, this resulted in $246.4 million of free cash flow driven by continued strength that included strong growth for Fleet®, Dramamine®, and Hydralyte® in our Gastrointestinal category, which helped partially offset the impacts of limited eye care production as well as ...